Efficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Immunosuppressive Therapy
Clinical trial NCT05323617 · WITHDRAWN
Trial details
- NCT number
- NCT05323617
- Sponsor
- Amgen
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-31
- Primary completion
- 2025-02-25
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.